ADAG Competitors & Alternatives
Compare Adagene Inc with similar stocks in the same industry
Biotechnology
ADAG
Main Stock$4.47
Tradestie Score
61
Market Cap
$94.26M
Revenue Growth
73.3%
Analyst Upside
+110.3%
Top Competitors
236 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
PROK
ProKidney Corp. Class A Ordinary Shares
|
$2.03
|
$350.98M | - | 57 | Compare |
|
ALT
Altimmune, Inc. Common Stock
|
$3.16
|
$341.56M | - | 59 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$5.46
|
$332.96M | - | 55 | Compare |
|
REPL
Replimune Group, Inc.
|
$11.58
|
$328.62M | - | 58 | Compare |
|
EDIT
Editas Medicine, Inc. Common Stock
|
$3.65
|
$319.22M | - | 55 | Compare |
|
CTNM
Contineum Therapeutics, Inc. Class A Common Stock
|
$15.10
|
$308.74M | - | 60 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$9.83
|
$304.12M | - | 59 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$21.51
|
$297.23M | - | 58 | Compare |
|
TECX
Tectonic Therapeutic, Inc. Common Stock
|
$37.93
|
$293.03M | - | 64 | Compare |
|
OMER
Omeros Corporation
|
$9.28
|
$281.75M | 8.3 | 51 | Compare |
More ADAG Analysis
Data updated: Jul 04, 2026 | Industry: Biotechnology (SIC 2834)
236 stocks in this industry